Trump directed a panel headed by HHS Secretary Robert F. Kennedy Jr. to assess “the prevalence of and threat” posed by SSRIs, ...

As Vitality becomes the first UK insurance provider to offer discounted weight-loss jab treatment, Yahoo UK spoke to them to ...

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

Until now, the drugs have only been available from specialist NHS clinics or private pharmacies, costing around £150 to £200 ...

Customers are to be offered discounted weight loss treatments through insurance giant Vitality in a UK first. The group, ...

Ratings has upgraded the issuer rating and senior unsecured notes ratings of global pharmaceutical company Eli Lilly and ...

The View' host Whoopi Goldberg said an Instagram ad is using an AI version of her likeness to sell weight loss drugs without her consent.

Weaker than expected data from the trial was a blow to Novo's ambitions to find a more powerful competitor to Lilly's Zepbound, also known as Mounjaro. CagriSema combines semaglutide, the active ...

Eli Lilly achieved the largest market capitalisation growth of 32.4% to $733bn in 2024, driven by strong demand for its weight-loss drugs, Mounjaro (tirzepatide) and Zepbound (tirzepatide).

Tirzepatide, the active ingredient in Eli Lilly's diabetes drug Mounjaro, may be an effective alternative to painful daily treatment for a rare disorder, according to research published Jan. 29 in ...

Ireland may be caught between the European continent and the United States in military powerplays, civil servants have warned Tánaiste Simon Harris. The new Defence Minister has been told Ireland ...